Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
US Stock MarketDetailed Quotes
KZR Kezar Life Sciences
- 5.710
- -0.180-3.06%
Close Feb 28 16:00 ET
- 5.710
- 0.0000.00%
Post 16:05 ET
41.66MMarket Cap-0.44P/E (TTM)
6.000High5.510Low123.68KVolume6.000Open5.890Pre Close717.93KTurnover2.72%Turnover RatioLossP/E (Static)7.30MShares10.60052wk High0.31P/B26.00MFloat Cap5.20252wk Low--Dividend TTM4.55MShs Float363.268Historical High--Div YieldTTM8.32%Amplitude5.200Historical Low5.804Avg Price1Lot Size
About Kezar Life Sciences Company
Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA.
Company Profile
SymbolKZR
Company NameKezar Life Sciences
Listing DateJun 21, 2018
Issue Price15.00
Founded2015
CEODr. Christopher Kirk, PhD
MarketNASDAQ
Employees58
Fiscal Year Ends12-31
Address4000 Shoreline Court,Suite 300
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-822-5600
Company Executives
- Name
- Position
- Salary
- Dr. Christopher Kirk, PhD
- Director and Chief Executive Officer
- 2.60M
- Mark C. Schiller
- Chief Legal Officer
- --
- Marc L. Belsky
- Chief Financial Officer and Secretary
- 2.01M
- Graham K. Cooper
- Chairman of the Board
- 194.56K
- John Franklin Fowler
- Director
- 4.83M
- Dr. Michael Glen Kauffman, M.D.,PhD
- Independent Director
- 155.34K
- Dr. Elizabeth Garner, M.D.
- Independent Director
- 149.45K
- Dr. Micki Klearman, M.D.
- Independent Director
- 161.58K
- Courtney Wallace
- Independent Director
- 164.59K
- Franklin M. Berger, C.F.A.
- Independent Director
- 141.22K